CJC-1295 with Ipamorelin
A combined peptide studied for growth-hormone signaling
Prescribed as CJC-1295 with Ipamorelin, after a consultation.
Book NowInterested in CJC-1295 with Ipamorelin?
CJC-1295 with Ipamorelin is offered through a quick consult with our medical team, who confirm it's right for you and handle scheduling.
Call or text (323) 655-8220Our team replies fast during clinic hours · Serving LA since 2010.
How it works
Book a consultation
Start online or in person. It only takes a minute, and the consultation can be done from home.
Meet with a nurse practitioner
They review your health history and your goals, and talk through whether a peptide is a good fit for you.
Get your prescription
If a peptide is appropriate, your provider writes the prescription. If it is not the right choice for you, they will tell you that too.
We order it for your visit
We order your peptide from our compounding pharmacy so it is ready for you. Your card is charged when the prescription is processed.
Important Information
Most peptides are not FDA-approved for the uses discussed publicly, and are prescribed at the discretion of a licensed provider after an individual evaluation. A peptide is not appropriate for everyone, and individual results vary.
Peptide therapy at Cienega Medical is available by prescription only. You start with a consultation with one of our nurse practitioners, who reviews your health history, your goals, and whether a peptide is appropriate for you. If it is, they write the prescription and we order it from our compounding pharmacy for your visit. If it is not, they will tell you that too.
What Is CJC-1295?
CJC-1295 is a laboratory-synthesized peptide structurally based on growth hormone-releasing hormone (GHRH). It was originally developed and studied in clinical research settings, and certain versions were investigated by pharmaceutical developers before development was discontinued. CJC-1295 is not approved by the U.S. Food and Drug Administration (FDA) for any use, and it is not an approved drug or dietary ingredient. It is classified as a research compound and is referenced in scientific literature primarily in the context of laboratory and investigational study.
FAQ
Click on a question to see more
-
What is CJC-1295?
CJC-1295 is a synthetic peptide developed as an analog of growth hormone-releasing hormone (GHRH). It has been the subject of scientific and pharmaceutical research. It is referenced in the literature as a research compound rather than as an approved medication.
-
Is CJC-1295 FDA-approved?
No. CJC-1295 is not approved by the U.S. Food and Drug Administration for any medical use. It is not an approved drug or dietary supplement ingredient and is generally categorized as a research-only compound.
-
Can I get CJC-1295 at Cienega Medical?
CJC-1295 is available by prescription following a nurse practitioner consultation. We prescribe it combined with Ipamorelin, which is how it is most commonly formulated. Neither peptide is FDA-approved. Your provider will review whether it is appropriate for you.
-
How do I start?
Book a consultation. One of our nurse practitioners will review your health history and goals with you, and if a peptide is appropriate they will write the prescription and we will order it for your visit. Your card is charged when the prescription is processed.
Cared for by our 12-person Los Angeles medical team. Meet your provider →
Visit us near you in West Hollywood, Santa Monica, and Calabasas
In-person, physician-supervised care at all three Cienega Medical clinics.
Book Online in Seconds
See real-time availability · Pick your time instantly
Serving LA since 2010 · 3,356 five-star reviews
Questions? Call us at (323) 655-8220
Book Now